NEW
YORK, Dec. 30, 2022 /PRNewswire/ -- Jakubowitz
Law announces that a securities fraud class action lawsuit has
commenced on behalf of shareholders of Twist Bioscience Corporation
(NASDAQ: TWST).
To receive updates on the lawsuit, fill out
the
form:
https://claimyourloss.com/securities/twist-bioscience-corporation-loss-submission-form/?id=35155&from=4
This lawsuit is on behalf of a class of all persons and entities
who purchased or otherwise acquired Twist common stock between
December 13, 2019 and November 14, 2022, inclusive.
Shareholders interested in acting as a lead plaintiff
representing the class of wronged shareholders have until
February 10, 2023 to petition
the court. Your ability to share in any recovery doesn't require
that you serve as a lead plaintiff.
According to a filed complaint, Twist Bioscience Corporation
issued materially false and/or misleading statements and/or failed
to disclose that: 1) as alleged in the November 15, 2022 report by Scorpion Capital,
defendants overstated the commercial viability of Twist's synthetic
DNA manufacturing technology; and 2) at the same time, defendants
were engaging in accounting fraud and using unsustainable pricing
to inflate the Company's true financial condition and
prospects.
Jakubowitz Law is vigorous in pursuit of justice for
shareholders who have been the victim of securities fraud. Attorney
advertising. Prior results do not guarantee similar outcomes.
CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887
View original
content:https://www.prnewswire.com/news-releases/twst-shareholder-alert-jakubowitz-law-reminds-twist-shareholders-of-a-lead-plaintiff-deadline-of-february-10-2023-301711258.html
SOURCE Jakubowitz Law